Jardiance — Revenue
Eli Lilly Jardiance — Revenue increased by 44.9% to $1.11B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.9%, from $1.01B to $1.11B. Over 4 years (FY 2021 to FY 2025), Jardiance — Revenue shows an upward trend with a 23.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing market adoption or successful expansion of the drug's therapeutic indications, while a decrease may signal increased competition, patent expiration, or loss of market share.
Detailed definition
This metric represents the total gross sales generated from a specific pharmaceutical product line within the company's...
Peer comparison
Comparable to product-level revenue reporting in other pharmaceutical companies, often categorized by therapeutic area or key brand performance.
lly_segment_jardiance_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $356.50M | $390.40M | $431.90M | $419.40M | $461.00M | $573.30M | $612.30M | $577.50M | $668.30M | $700.80M | $798.40M | $686.50M | $769.60M | $686.40M | $1.20B | $1.01B | $690.00M | $959.00M | $768.60M | $1.11B |
| QoQ Change | — | +9.5% | +10.6% | -2.9% | +9.9% | +24.4% | +6.8% | -5.7% | +15.7% | +4.9% | +13.9% | -14.0% | +12.1% | -10.8% | +74.6% | -15.4% | -32.0% | +39.0% | -19.9% | +44.9% |
| YoY Change | — | — | — | — | +29.3% | +46.8% | +41.8% | +37.7% | +45.0% | +22.2% | +30.4% | +18.9% | +15.2% | -2.1% | +50.1% | +47.7% | -10.3% | +39.7% | -35.9% | +9.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's jardiance — revenue?
- Eli Lilly (LLY) reported jardiance — revenue of $1.11B in Q1 2026.
- How has Eli Lilly's jardiance — revenue changed year-over-year?
- Eli Lilly's jardiance — revenue increased by 9.9% year-over-year, from $1.01B to $1.11B.
- What is the long-term trend for Eli Lilly's jardiance — revenue?
- Over 4 years (2021 to 2025), Eli Lilly's jardiance — revenue has grown at a 23.2% compound annual growth rate (CAGR), from $1.49B to $3.43B.
- What does jardiance — revenue mean?
- The total amount of money earned from sales of a specific drug product.